RLAY Relay Therapeutics, Inc. Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
12:49
Aug 17
seedy19tron Biotech trader, L/S
Reports most added positions across funds
"Reports most added positions across specialist funds from Q1 to Q2 2026, no directional view."
RLAY
MED
11:50
Aug 17
seedy19tron Biotech trader, L/S
Reports most added positions by specialist funds
Reports the most added positions by specialist funds from Q1 to Q2 2026.
RLAY
MED
10:04
May 19
seedy19tron Biotech trader, L/S
Reports Phase 1/2 clinical data for RLY-2608 showing 60% volumetric response rate.
Reports Phase 1/2 clinical data for RLY-2608 showing 60% volumetric response rate in PIK3CA-mutant tumors, no directional view stated.
RLAY
HIGH

About RLAY Analyst Coverage

Buzzberg tracks RLAY (Relay Therapeutics, Inc.) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 3 total trade ideas tracked. Latest voices: seedy19tron.